For: | Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183 [PMID: 28533674 DOI: 10.3748/wjg.v23.i17.3174] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm |
Number | Citing Articles |
1 |
Mirjam C. M. van der Ende-van Loon, A. Stoker, P. T. Nieuwkerk, W. L. Curvers, E. J. Schoon. How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements. Quality of Life Research 2022; 31(6): 1639 doi: 10.1007/s11136-021-03009-7
|
2 |
Pietro Crispino, Tiziana Ciarambino, Mauro Giordano. Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens. Current Issues in Molecular Biology 2023; 45(6): 4701 doi: 10.3390/cimb45060299
|
3 |
S Szachnowicz, A F Duarte, A Nasi, J R M da Rocha, F B Seguro, E T Bianchi, F Tustumi, E G H de Moura, R A A Sallum, I Cecconello. Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett’s esophagus: a long-term analysis. Diseases of the Esophagus 2022; 35(11) doi: 10.1093/dote/doac026
|